HA-Tag Antibody

What is the HA-tag sequence and why is it commonly used in molecular biology?

The HA-tag corresponds to amino acid residues YPYDVPDYA derived from the human influenza virus hemagglutinin (HA) protein . This tag is widely used in biotechnology because:

• It is relatively small and typically doesn't interfere with the bioactivity or biodistribution of recombinant proteins

• It can be positioned at either the N-terminus, C-terminus, or internally within a target protein

• Several inexpensive anti-HA antibodies are commercially available

• It works efficiently across numerous expression systems

The tag facilitates detection, isolation, and purification of proteins without requiring protein-specific antibodies, making it an economical and versatile tool for protein studies .

What applications can HA-tag antibodies be used for?

HA-tag antibodies have been validated for multiple applications in molecular and cellular biology:

Cited applications in research include 657 publications for Western blot and 189 publications for immunoprecipitation with a single antibody (51064-2-AP) .

How do I choose between monoclonal and polyclonal HA-tag antibodies?

The choice depends on your experimental requirements:

Monoclonal Antibodies (e.g., clone 912426 , 2-2.2.14 ):

• Advantages: High specificity to a single epitope, consistent lot-to-lot performance, lower background

• Best for: Quantitative experiments, applications requiring high reproducibility

• Example: Mouse Anti-HA Peptide Monoclonal Antibody (MAB6875) detects specific bands for HA-tagged proteins at expected molecular weights with minimal background

Polyclonal Antibodies (e.g., AHP1075 , 51064-2-AP ):

• Advantages: Recognize multiple epitopes, potentially higher sensitivity

• Best for: Applications where signal amplification is needed

• Example: Rabbit anti-HA-Tag polyclonal has been tested against both the immunogen and recombinant proteins containing the HA sequence, showing recognition regardless of tag position

How can I optimize detection of HA-tagged proteins in Western blot?

Optimizing Western blot detection requires systematic protocol adjustments:

• Sample Preparation:

  • Use proper lysis buffers based on protein localization (membrane, cytosolic, nuclear)

  • Include protease inhibitors to prevent degradation

  • For difficult proteins, consider specialized buffers

• Antibody Selection and Dilution:

  • Test primary antibody dilutions from 1:5000-1:50000 for optimal signal-to-noise ratio

  • Example data: When comparing antibody performance, GenScript (A01244) showed greater sensitivity than Abcam (Clone 12CA5) at the same concentration (1 μg/ml) for N-terminal, C-terminal, and internal HA tags

• Membrane Type:

  • PVDF membrane works well for most applications

  • Example protocol: PVDF membrane probed with 0.5 μg/mL Mouse Anti-HA Peptide Monoclonal Antibody followed by HRP-conjugated secondary antibody

• Blocking Conditions:

  • 5% milk in TBS-T for 1 hour at room temperature is standard

  • 1% milk can be used for antibody dilution during overnight incubation

• Detection System:

  • Chemiluminescence works well for most applications

  • For quantitative analysis, consider fluorescent secondary antibodies

How do I properly design an HA-tag competition assay for protein quantification?

Based on research protocols, an effective HA-tag competition assay can be designed as follows :

• Assay Principle:

  • The competition assay relies on the principle that each in vitro translated peptide or protein containing a single HA tag should interact with the anti-HA antibody with equal affinity

  • This enables quantification independent of the sequence N-terminal to the HA tag

• Materials Required:

  • Synthetic fluorescently labeled HA peptide (signal generator)

  • Unlabeled synthetic HA peptide (for standard curve)

  • Anti-HA antibody

  • In vitro translated samples with HA tags

  • Appropriate controls (e.g., samples lacking HA tag)

• Protocol Outline:

  • Generate signals using synthetic fluoresceinated HA peptide

  • Create a standard curve using unlabeled synthetic peptide as competitor

  • Prepare serial dilutions of samples (e.g., 1:10 followed by four 1:2 dilutions)

  • Normalize matrix effects by diluting all samples and standards in the same solution

  • Measure signal reduction as a function of HA-tagged protein concentration

• Validation:

  • Include positive controls (known HA-tagged proteins of different sizes)

  • Include negative controls (e.g., proteins without HA tag)

  • Example: In research by PMC4030805, Pep1, Pep2, and ScPep1 all showed reduction of signal in the competition assay, while Pep1ΔHA (lacking HA tag) did not

What are the best practices for immunofluorescence detection of HA-tagged proteins?

Research-validated immunofluorescence protocols follow these steps :

• Cell Preparation:

  • Culture cells on coverslips or in chamber slides

  • Transfect with HA-tagged construct (allow 24-48 hours for expression)

• Fixation Options:

  • Paraformaldehyde (4%) for 10 minutes (standard)

  • Methanol for 15 minutes at -20°C (alternative)

  • Note: A comparative study showed similar results with both fixation methods for most anti-HA antibodies

• Permeabilization:

  • 0.1% Triton X-100 for 15 minutes at room temperature

• Blocking:

  • 2% BSA for 1 hour at room temperature

• Antibody Incubation:

  • Primary: Anti-HA antibody at 2-8 μg/mL in 0.1% BSA, overnight at 4°C

  • Secondary: Fluorophore-conjugated secondary antibody (e.g., Alexa Fluor 488) at 1:2,000 dilution for 45 minutes at room temperature

• Counterstaining:

  • Nuclei: DAPI (blue)

  • Optional: F-actin with phalloidin (red)

• Mounting and Imaging:

  • Mount with antifade mounting medium

  • Image at 60× magnification

• Controls:

  • Untransfected cells

  • Secondary antibody only (no primary) to assess background

Why do I see multiple bands or high background in my Western blot with HA-tag antibodies?

Multiple bands or high background can result from several factors:

A customer review noted: "This antibody recognized the HA-tagged proteins, but also got a lot of non-specific bands" when used at 1:2000 dilution . Another review states: "No background observed and clean bands" when following recommended dilutions , highlighting the importance of proper optimization.

How do I verify the specificity of my HA-tag antibody?

To verify antibody specificity:

• Control Experiments:

  • Include untransfected/untreated cells or lysates as negative controls

  • Include known HA-tagged proteins as positive controls

  • Example: Western blot analysis should show absence of signal in untransfected cells (Lane 4) but clear signal in transfected samples

• Peptide Competition:

  • Pre-incubate antibody with synthetic HA peptide

  • Should significantly reduce or eliminate specific signal

  • Example: In a competition assay, concentrations higher than 1 nM of unlabeled peptide significantly reduced signal

• Cross-Reactivity Testing:

  • Test against bacterial extracts (should show no cross-reactivity with endogenous proteins)

  • Some antibodies have been tested against human protein arrays to identify potential cross-reactivity

  • Example: Clone TANA2 was found to recognize 9 human proteins containing the PDY sequence in addition to the HA tag

• Tag Deletion:

  • Compare signal between full HA-tagged construct and construct with deleted tag

  • Example: Pep1ΔHA (lacking HA tag) showed no signal in competition assay while Pep1 with tag did

What factors affect the sensitivity of HA-tag antibody detection?

Several factors influence detection sensitivity:

• Tag Position Effect:

  • Comparative studies have shown differential detection based on tag location

  • GenScript (A01244) showed varying sensitivity for N-terminal, C-terminal, and internal HA tags

  • Consider testing multiple antibody clones if tag accessibility is a concern

• Antibody Concentration:

  • A dilution series experiment with anti-HA AF291 antibody showed that a 1:100 dilution caused only a 60% decrease in signal

  • This suggests that many protocols use antibody concentrations far higher than needed

• Secondary Antibody Limitation:

  • In immunofluorescence, the secondary antibody concentration can be a limiting factor

  • A dilution of secondary antibody caused an approximately proportional decrease in observed signal

• Multimeric Tags:

  • 3× HA tags (HAx3, YPYDVPDYAGYPYDVPDYAGYPYDVPDYA) significantly improve antibody affinity

  • Example: Roche 3F10 clone antibody has Kd of 0.38 nM for standard HA but 0.067 nM for HAx3

How can I design an effective target-binding assay using HA-tagged proteins?

A sophisticated sandwich assay design for target binding assessment with HA-tagged proteins can be implemented as follows :

• AMMP Target-Binding Assay Design:

  • Immobilize target protein (e.g., Bcl-xL) on magnetic beads

  • Allow binding of HA-tagged synthetic peptides to the target

  • Use fluoresceinated anti-HA antibody that binds to both the HA-tagged peptide and antifluorescein antibody on the sensor surface

  • This links the magnetic bead to the sensor surface

• Alternative Radiolabeled Binding Assay:

  • Immobilize target protein on magnetic beads

  • Test binding of 35S-labeled, HA-tagged peptides

  • Measure binding through radiometric detection

  • Example: This approach demonstrated different binding affinities of Pep1, Pep2, and ScPep1 to Bcl-xL

• Controls and Validation:

  • Include non-binding peptides as negative controls

  • Include peptides with known binding constants as standards

  • Verify assay sensitivity and dynamic range

• Quantification:

  • Establish relationship between signal intensity and binding affinity

  • Use the HA tag competition assay (described earlier) to normalize for peptide concentration

What are the considerations for using HA-tag antibodies in various species and expression systems?

Research data supports these considerations:

• Species Compatibility:

  • HA-tag antibodies typically work across species as they recognize the tag rather than endogenous proteins

  • Cited reactivity includes human, mouse, and pig samples

  • The tag sequence is not naturally present in most experimental organisms, reducing background

• Expression Systems:

  • HA tags function in virtually all expression systems, including:

    • Mammalian cell lines (HEK293, HeLa, etc.)

    • Bacterial expression systems

    • Insect cells

    • In vitro translation systems

  • The tag can be added to either C- or N-terminus depending on experimental requirements

• Context-Dependent Recognition:

  • Some antibody clones (e.g., 12CA5) might display context-dependent affinities

  • Protein structure may affect tag accessibility

  • Solution: Use multiple HA tag copies or test different tag positions

• Cell Type-Specific Factors:

  • In immunofluorescence applications, different cell types may require optimization of fixation methods

  • Example: S2 cells transfected with HA-tagged Rab11 showed successful immunostaining with anti-HA antibodies

How do HA-tag antibodies compare to other tag systems in advanced research applications?

A comparative analysis based on research data:

Recent quantitative research concluded: "For researchers initiating a new project, the use of the HA or DYKDDDDK tags appears as a good choice" . Additionally: "Only AF291 (anti-HA), TA001 (anti-DYKDDDDK), and AV248 (anti-6xHis) are devoid of intellectual property, allowing them to be produced and used with no restrictions" .

What advancements allow for prediction of antibody specificity based on sequence?

Recent developments in antibody research using HA-targeted antibodies have led to exciting advances in specificity prediction:

• Memory B Cell Language Model (mBLM):

  • A lightweight language model developed for sequence-based antibody specificity prediction

  • Trained on >5,000 influenza hemagglutinin (HA) antibodies mined from research publications and patents

  • Capable of distinguishing antibodies targeting HA head versus stem domains

• Key Findings from Model Development:

  • HA head and stem antibodies have distinct sequence features

  • CDR H3 sequences of HA stem antibodies showed significantly higher hydrophobicity than HA head antibodies (p = 0.001)

  • The tip of CDR H3 showed even more pronounced hydrophobicity differences (p = 4e-12)

  • No significant difference in CDR H3 length was observed between antibody types (p = 0.38)

• Validation and Applications:

  • The model successfully identified residues critical for binding

  • Applied to 4,452 HA antibodies with unknown epitopes, predicting 40% as HA stem antibodies

  • Experimental validation confirmed predictions

• Implications for Research:

  • This approach can accelerate epitope mapping without extensive experimental work

  • The model can potentially be extended to predict other antibody specificities

  • Demonstrates the value of data mining and machine learning in antibody research